Clinical

Dataset Information

0

Phase II study of oxaliplatin based regimen in relapsed colon cancer patients treated with oxaliplatin based adjuvant

ABSTRACT: Interventions: Oxaliplatin fluoropyrimidine molecularly targeted drug Primary outcome(s): Progression free survival Study Design: Single arm Non-randomized

DISEASE(S): Colorectal Cancer

PROVIDER: 2626719 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Json Xml

Similar Datasets

Unknown Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.
| S-EPMC3274510 | biostudies-literature
Unknown Maintenance tegafur-uracil versus observation following an adjuvant oxaliplatin-based regimen in patients with stage III colon cancer after radical resection: study protocol for a randomized controlled trial.
| S-EPMC5405502 | biostudies-literature
Unknown A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen.
| S-EPMC3859145 | biostudies-literature
Unknown <i>SLF1</i> polymorphism predicts response to oxaliplatin-based adjuvant chemotherapy in patients with colon cancer.
| S-EPMC8085871 | biostudies-literature
Unknown ERCC1, XRCC1 and GSTP1 Single Nucleotide Polymorphisms and Survival of Patients with Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy.
| S-EPMC4026996 | biostudies-literature
Unknown Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7.
| S-EPMC3058288 | biostudies-literature
Unknown The effects of oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with mismatch repair-deficient: a retrospective study.
| S-EPMC10835817 | biostudies-literature
Unknown Immunoscore Is Prognostic in Low-Risk and High-Risk Stage III Colon Carcinomas Treated With Adjuvant Infusional Fluorouracil, Leucovorin, and Oxaliplatin in a Phase III Trial.
| S-EPMC9384943 | biostudies-literature
Unknown Association of High LAT1 Expression with Poor Prognosis and Recurrence in Colorectal Cancer Patients Treated with Oxaliplatin-Based Adjuvant Chemotherapy.
| S-EPMC9916902 | biostudies-literature
Unknown Real-World Effectiveness of Adjuvant Oxaliplatin Chemotherapy in Stage III Colon Cancer: A Controlled Interrupted Time Series Analysis.
| S-EPMC8276019 | biostudies-literature